Pfizer (PFE) Stock Rallies on November 21, 2025 as Investors Focus on FDA Win, Obesity Pivot and 7% Dividend Yield
Pfizer finished Friday’s session on a strong note, with the stock climbing as investors digested a fresh U.S. FDA approval in bladder cancer, progress…

















